AMSTERDAM, Nov. 17, 2016 /PRNewswire/ -- Royal
Philips (NSYE: PHG, AEX: PHIA) today announced the
introduction of a suite of magnetic resonance (MR)-based software
applications dedicated to neurology, which will debut at the
Radiological Society of North
America's (RSNA) 102nd Scientific Meeting and
Annual Assembly in Chicago (US)
later this month. With these introductions for its Ingenia family
of digital MRI systems, Philips is reinforcing its global
leadership in Neuro MR software applications [1], providing
radiologists with the necessary tools to resolve complex health
questions and explore new territories in neurology.
More than one billion people worldwide are affected by
neurological disorders, which most commonly include Alzheimer's,
dementia, stroke, traumatic brain injury and multiple sclerosis.
According to the World Health Organization, neurological disorders
are the leading global burden of disease (economic and health
impact), and as an aging population grows, the identification and
treatment of these disorders becomes a critical priority in
population health management.
Advanced diagnostics are a critical part of the treatment
protocol for neurological disorders. With its superb 3D imaging of
soft tissue, Magnetic Resonance Imaging (MRI) can produce a wealth
of structural and physiological information of the brain. It has
therefore become a standard in neuroimaging, with 65 percent of
neurologists leveraging MR technology over alternative methods [2].
However, 70 percent of physicians often face challenges with their
existing neuro-diagnostic tools, which lack effective imaging and
visualization techniques [3]. Philips' new suite of
neuro-diagnostic applications provides physicians with a
comprehensive portfolio of tools designed with the patient in mind,
delivering visibility into neurological anatomies and
multi-dimensional data to enable diagnostic decision support.
"In a society where neurological disorders impact a large
population, continued innovation is critical in improving
diagnostic clarity and treatment guidance for all neurological
patients," said Eric Jean, General
Manager of MRI at Philips. "We need to advance a field that has an
abundant amount of health information yet to be discovered. Our new
suite of decision support solutions will empower radiologists with
actionable insights to make fast diagnoses to help improve the
patient experience and health outcomes overall, while at the same
time reducing cost."
The suite of neuro-diagnostic applications will be available on
Philips' Ingenia family of MRI systems, utilizing Philips' dStream
digital broadband architecture technology to provide high quality
images at remarkable speed. Unique features include:
- Black Blood Imaging – Boosts diagnostic confidence for
radiologists by providing a high resolution 3D brain image with
reduction of the blood signal [4], resulting in higher image
quality and giving radiologists deeper insights.
- 4D-TRANCE – Provides contrast-free dynamic (4D) imaging
of the brain vascular anatomy. 4D TRANCE is a non-contrast
technique promoting patient comfort and enabling radiologists to
evaluate both the vascular anatomy and blood flow dynamics.
- MultiBand SENSE – Allows simultaneous acquisition
of multiple slices in the brain in fMRI exams, enabling accelerated
neurofunctional scans at high speed and high resolution [5]. This
feature provides radiologists the option to increase coverage or
resolution without increasing scan time.
The suite of neuro-diagnostic applications will also be
seamlessly integrated into the latest version of the Philips
IntelliSpace Portal, also planned to make its debut at the RSNA
annual meeting in Chicago. With
the IntelliSpace Portal, radiologists have access to the latest
clinical capabilities covering their advanced visual analysis needs
on a single platform to provide a comprehensive overview of the
patient for quick detection, confident diagnosis and efficient
follow-up. This newest version of Philips IntelliSpace Portal
places greater focus on enhanced depth of clinical analysis in
neurology, for even the most complex patients.
Philips will be showcasing its latest neuro-diagnostic
applications at RSNA 2016 at booth #6735 in Hall B at McCormick
Place. For more information about Philips' presence at RSNA,
including the full suite of Philips MR imaging solutions, please
visit Philips' RSNA event website, and follow @PhilipsLiveFrom for
more information on Philips' presence at #RSNA16.
[1] Internal data on file. Overview of the clinical application
portfolios for Neuro MRI for Philips, 2016
[2] Data from Advisory Council worksheet on procedure growth
2009
[3] TMTG Market Survey 2016
[4] Compared to our 3D T1w scan without MSDE pre-pulse
[5] High speed due to using MultiBand SENSE and high resolution due
to using in-plane dS SENSE
For further information, please contact:
Alicia Cafardi
Philips Group Communications
Tel: + 1 412-523-9616
Email: alicia.cafardi@philips.com
Kathy O'Reilly
Philips Group Communications
Tel: +1 978-221-8919
Email: kathy.oreilly@philips.com
@kathyoreilly
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving
people's health and enabling better outcomes across the health
continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips' health
technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Photo - http://photos.prnewswire.com/prnh/20161116/440541
Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-to-unveil-suite-of-advanced-mr-based-software-applications-for-assessment-of-neurological-disorders-at-rsna-2016-300364963.html
SOURCE Royal Philips